Gyre Therapeutics:指引反映Etorel商业化进程慢于预期,因中国集中采购政策的不确定性
Gyre Therapeutics:指引反映Etorel商业化进程慢于预期,因中国集中采购政策的不确定性
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.